Serious Liver Injury Tied to HCV Drugs in Rare Cases, FDA Warns Serious Liver Injury Tied to HCV Drugs in Rare Cases, FDA Warns

The US Food and Drug Agency has warned that three direct-acting antiviral drugs have been associated with rare cases of severe liver injury in patients being treated for hepatitis C virus infection.News Alerts
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Gastroenterology News Alert Source Type: news